Literature DB >> 7432047

Toxic epidermal necrolysis.

J Rasmussen.   

Abstract

Toxic epidermal necrolysis is one of the rarest events -- a dermatologic emergency. The clinical presentation is characteristic -- disseminate erythema and widespread bullous necrosis of the epidermis and mucous membranes. Toxicity is universal and mortality is substantial even with prompt and intensive therapy. Drugs are the most commonly incriminated agents and therapy remains controversial, the majority favoring high-dose systemic corticosteroids.

Entities:  

Mesh:

Year:  1980        PMID: 7432047     DOI: 10.1016/s0025-7125(16)31573-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  7 in total

1.  Toxic epidermal necrolysis: a burn-centre challenge.

Authors:  W Peters; J Zaidi; L Douglas
Journal:  CMAJ       Date:  1991-06-01       Impact factor: 8.262

Review 2.  Stevens-Johnson syndrome: a review of the literature.

Authors:  V J Stitt
Journal:  J Natl Med Assoc       Date:  1988-01       Impact factor: 1.798

3.  Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids.

Authors:  P H Halebian; V J Corder; M R Madden; J L Finklestein; G T Shires
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

4.  Fatal toxic epidermal necrolysis associated with Hodgkin's disease.

Authors:  J A Newton; E Martin-Bates; D H McGibbon; P H McKee
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

5.  Toxic epidermal necrolysis occurring during treatment with trimethoprim alone.

Authors:  C Nwokolo; L Byrne; K J Misch
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-02

6.  Stevens-Johnson syndrome managed in the Clinitron bed.

Authors:  P Davies; D W Ryan
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

Review 7.  Analgesics, allergy and asthma.

Authors:  A Szczeklik
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.